Literature DB >> 22227821

Comprehensive MRI analysis of early cardiac and vascular remodeling in middle-aged patients with abdominal obesity.

Damien Mandry1, Romain Eschalier, Anna Kearney-Schwartz, Patrick Rossignol, Laure Joly, Wassila Djaballah, Philip Böhme, Jean M Escanyé, Pierre A Vuissoz, Renaud Fay, Faïez Zannad, Pierre Y Marie.   

Abstract

OBJECTIVES: To determine, using a comprehensive MRI investigation, prevalence and vascular correlates of early left-ventricular concentric remodeling in middle-aged patients with abdominal obesity. Left-ventricular and vascular remodeling are commonly associated with hypertension, but little is known for abdominal obesity patients, a population with definite increase in cardiovascular risk and high rates of further developments of hypertension and of the metabolic syndrome.
METHODS: Seventy middle-aged abdominal obesity patients (56 ± 5 years, 49% women, 69% with body mass index > 30 kg/m), who had no additional cardiovascular risk factor except for untreated stage 1 hypertension (16%), and 40 controls underwent MRI for detecting concentric remodeling (increase in left-ventricular mass/end-diastolic volume ratio) and identifying potential determinants, including arterial compliance indexes [aortic pulse wave velocity and total arterial compliance (TAC)] and total peripheral vascular resistances (TPVRs).
RESULTS: Twenty abdominal obesity patients (29%) had concentric remodeling (concentric remodeling+), whereas 50 did not (concentric remodeling-). Concentric remodeling+ patients were mostly men (85%), they frequently had stage 1 hypertension (45%) and few had left-ventricular hypertrophy (20%). When adjusted for sex, there was a step-by-step decline in TAC between controls (mean ± SEM: 2.10 ± 0.06 ml/mmHg), concentric remodeling- (1.82 ± 0.06 ml/mmHg) and concentric remodeling+ (1.42 ± 0.09 ml/mmHg, P < 0.005 for inter-group comparisons) and TPVRs were lower than controls for concentric remodeling- (14.7 ± 0.5 vs. 16.8 ± 0.5 ml/mmHg, P = 0.005) but not for concentric remodeling+ (17.5 ± 0.7 mmHg/min per l).
CONCLUSIONS: Concentric remodeling is frequently documented by MRI in the middle-aged men with abdominal obesity and in association with a decrease in TAC no longer counter-balanced by a decrease in TPVR, suggesting a remodeling from proximal to peripheral vasculature.

Entities:  

Mesh:

Year:  2012        PMID: 22227821     DOI: 10.1097/HJH.0b013e32834f6f3f

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Correlation between left ventricular myocardial strain and left ventricular geometry in healthy adults: a cardiovascular magnetic resonance-feature tracking study.

Authors:  Zhen Zhang; Qiaozhi Ma; Lizhen Cao; Zhiwei Zhao; Jun Zhao; Qing Lu; Linan Zeng; Mingzhu Zhang; Gerald M Pohost; Kuncheng Li
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-12       Impact factor: 2.357

2.  Influence of Thoracic Aortic Inflammation and Calcifications on Arterial Stiffness and Cardiac Function in Older Subjects.

Authors:  L Joly; D Mandry; A Verger; C Labat; G Watfa; V Roux; G Karcher; P-Y Marie; A Benetos
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

3.  Effects of Exercise and Weight Loss on Proximal Aortic Stiffness in Older Adults With Obesity.

Authors:  Tina E Brinkley; Iris Leng; Margie J Bailey; Denise K Houston; Christina E Hugenschmidt; Barbara J Nicklas; W Gregory Hundley
Journal:  Circulation       Date:  2021-08-02       Impact factor: 39.918

4.  Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance.

Authors:  Olivier Huttin; Damien Mandry; Romain Eschalier; Lin Zhang; Emilien Micard; Freddy Odille; Marine Beaumont; Renaud Fay; Jacques Felblinger; Edoardo Camenzind; Faïez Zannad; Nicolas Girerd; Pierre Y Marie
Journal:  J Cardiovasc Magn Reson       Date:  2017-01-04       Impact factor: 5.364

5.  Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study.

Authors:  Yue Gao; Yan Ren; Ying-Kun Guo; Xi Liu; Lin-Jun Xie; Li Jiang; Meng-Ting Shen; Ming-Yan Deng; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2020-05-29       Impact factor: 9.951

6.  Relationship Between Left Ventricular Ejection Fraction Variation and Systemic Vascular Resistance: A Prospective Cardiovascular Magnetic Resonance Study.

Authors:  Damien Mandry; Nicolas Girerd; Zohra Lamiral; Olivier Huttin; Laura Filippetti; Emilien Micard; Marine Beaumont; Marie-Paule Bernadette Ncho Mottoh; Nathalie Pace; Faïez Zannad; Patrick Rossignol; Pierre-Yves Marie
Journal:  Front Cardiovasc Med       Date:  2021-12-24

7.  Cardiac steatosis and left ventricular function in men with metabolic syndrome.

Authors:  Kristofer Nyman; Marit Granér; Markku O Pentikäinen; Jesper Lundbom; Antti Hakkarainen; Reijo Sirén; Markku S Nieminen; Marja-Riitta Taskinen; Nina Lundbom; Kirsi Lauerma
Journal:  J Cardiovasc Magn Reson       Date:  2013-11-14       Impact factor: 5.364

8.  Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study.

Authors:  Christopher D Maroules; Amit Khera; Colby Ayers; Akshay Goel; Ronald M Peshock; Suhny Abbara; Kevin S King
Journal:  J Cardiovasc Magn Reson       Date:  2014-05-14       Impact factor: 5.364

9.  Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study.

Authors:  Olivier Huttin; Damien Mandry; Batric Popovic; Patrick Rossignol; Freddy Odille; Emilien Micard; Zohra Lamiral; Faïez Zannad; Nicolas Girerd; Pierre-Yves Marie
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.